Abiopharma

🔍 Akgonul Rifat Kerim (Executive)

Company: PEGASYSTEMS INC (PEGA)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 1,176 shares of Common stock (Direct)
  Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 109,225.00 | transaction_form_type: 4
• Sold 569 shares of Common stock at $36.81 per share (Direct)
  Date: 2026-09-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 108,656.00 | transaction_form_type: 4
• Sold 1,176 shares of Restricted Stock Units (Derivative)
  Date: 2026-09-01 | Code: M | Expires: 2027-03-01 | Exercise: 2023-03-01 | equity_swap_involved: 0 | shares_owned_after: 2,350.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Each restricted stock unit represents the right to receive, following vesting, one share of common stock.
• F2: 20% of the restricted stock units vested on the Date Exercisable in Table II, and the remaining 80% vest in equal quarterly installments over the following four years.